Professional Documents
Culture Documents
Autogenousvaccine CUTANEOUS BOVINE PAPILLOMATOSIS
Autogenousvaccine CUTANEOUS BOVINE PAPILLOMATOSIS
Abstract
Efficacy of autogenous vaccine and auto-hemotherapy were tested in cattle suffering from papillomatosis. Five
doses of autogenous vaccines were injected on day 1, 3, 5, 7 and 9 to each animal. For auto-hemotherapy, 10 ml of
venous blood was injected intramuscularly on weekly interval for four weeks. The animals given autogenous vaccine
alone took two months to recover, while animals given both autogenous vaccine and auto-hemotherapy recovered
within one and a half month. Results of the present study suggest that autogenous vaccine is useful for therapeutic
purposes in bovine papillomatosis and auto-hemotherapy can serve as an useful adjunct by enhancing regression
rate of papillomas.
Keywords: Auto-hemotherapy; autogenous vaccine; cattle; papillomatosis
Downloaded From IP - 117.220.146.172 on dated 28-Nov-2016
411
Bovine cutaneous papillomatosis
cattle had very small 5-10 small papillomas in the Whatman filter paper no. 1. Formalin solution (2
neck and abdominal region. The four moderately ml) and 1.5 g gentamicin sulfate was added to the
affected animals were selected for the treatment mixture and the solution obtained was stored at
and the rest two were left untreated to serve as 40C for 2 days (Fig. 2). Thereafter, 1, 2, 3, 4 and 5
positive control. Out of four animals, two received ml of this autogenous vaccine was administered
only autogenous vaccine (group 1) while two other subcutaneously to each animal on day 1, 3, 5, 7
received autogenous vaccine alongwith auto- and 9 respectively. For auto-hemotherapy, 10 ml
hemotherapy (group 2). All six animals were kept of venous blood was collected by jugular
isolated in a shed located in the corner of the venipuncture and injected deep intramuscularly
dairy farm. in the same animal at weekly interval for four
weeks. No adverse reaction of vaccination or auto-
For preparation of autogenous killed vaccine,
hemotherapy was observed in any animal. Marked
papillomas with different colour and morphology,
improvement in the condition was noted after 3
i.e. sessile and pedunculated, dark and light
coloured were collected after surgical incision weeks in both groups, characterized by
randomly from all the four animals. They were progressive degeneration of wart tissues,
trichurated using a mortar and pestle. Twenty shedding of old papillomas and non-appearance
gram of the trichurated papilloma tissues was of fresh warts (Fig. 3). However, the rate of
Downloaded From IP - 117.220.146.172 on dated 28-Nov-2016
mixed with 500 ml sterile Normal Saline Solution regression of warts was slow in group 1 as
and the mixture obtained was filtered using compared to group 2 animals. Almost complete
Members Copy, Not for Commercial Sale
www.IndianJournals.com
Fig. 1: Heifer severely affected from papillomatosis Fig. 2: The prepared autogenous vaccine
412
Ranjan et al.
characterized types of BPV-1 to 10. The However, there seems paucity of reports available
co-infection by multiple BPV is also common on use of auto-hemotherapy in veterinary practice.
which is responsible for variation in morphology Auto-hemotherapy was reported to cause
of the papillomas developing in the affected animal complete cure of papillomatosis in a cattle
(Freitas et al., 2011). In the present study, size, (Kumar, 2011). Auto-hemotherapy is believed to
shape and colour of papillomas were variable, stimulate the reticulo-endothelial system and to
suggesting involvement of several types of bovine increase population of macrophages in circulating
papilloma viruses. blood, which might be responsible for enhancing
The pathogenesis of papillomatosis is governed regression rate of the papillomas. Concurrent
by several factors including inheritance, nutritional administration of parammunity inducers support
and hormonal disorders, sunlight and rapid regression of warts and enhancing efficacy
suppressed immune system (Campo et al., 1994). of autogenous vaccines (Inayat et al., 1999; Turk
There is significant relationship between et al., 2005). However, further large-scale study
development of papillomas and immune status of is required to elucidate the mechanism of action
the host. The disease occurs in severe form in of auto-hemotherapy.
mostly immunocompromised patients. This From the present study, it can be concluded that
phenomenon is well documented in human
Downloaded From IP - 117.220.146.172 on dated 28-Nov-2016
occasionally persist and in the presence of These two therapeutic modalities are low cost and
www.IndianJournals.com
additional critical genetic or environmental factors, easy to follow, hence can be applied at field level.
can progress to cancer (Campo et al., 1994). The
regression of papillomas is mediated by cellular References
immunity. Paulik et al. (2001) noted that Borku, M.K., Atalay, O., Kibar, M., Cam, Y. and Atasever,
A. (2007). Ivermectin is an effective treatment for bovine
blastogenic activity of lymphocytes decrease in
cutaneous papillomatosis. Res. Vet. Sci. 83: 360-63.
bulls suffering from persisting cutaneous
papillomatosis and use of autologous vaccine led Campo, M.S., Jarrett, W.F., O’neil, W., Baron, R.J.
to continual regression of the tumors and gradual (1994). Latent papillomavirus infection in cattle. Res.
elevation of lymphocytic activity. Unfortunately, no Vet. Sci. 56: 151-57.
effective commercial prophylactic or therapeutic Dileepkumar, K.M., Ansari, M.M. (2012). Therapeutic
vaccines against papillomatosis are available in management of cutaneous papillomatosis in a buffalo
the Indian market (Maeda et al., 2007). By large, calf. Intas Polivet 13: 67-69.
autogenous vaccines are used for therapy that Freitas, A.C., Silva, M.A.R., Jesus, A.L.S., Mariz, F.C.,
gives variable response (Sreeparvathy et al., Cordeiro, M.N., Albuquerque, B.M. F. and Batista,
2011). The autogenous vaccines stimulate the M.V.A. (2011). Recent insights into bovine
immune system against the papilloma viruses. The papillomavirus. African J Microbiol Res. 5: 6004-12.
variation of response may be attributed to type of
Inayat, A., Muhammed, G., Asi, M.N., Saqib, M. and
virus involved, developmental stages of
Athar, M. (1999). Use of autogenous vaccine for the
papillomas, method of collection of papilloma
treatment of generalized papillomatosis in cattle. Pakistan
tissues and preparation of vaccine, schedule of Vet. J. 19: 102-03.
administration and immune function of the patient.
Jelinek , E. and Tac hezy , R. (2005). Cutaneous
In the present study, rapid regression of warts in papillomatosis in cattle. J. Comp. Pathol. 132: 70-81.
group 2 animals suggested that auto-
hemotherapy is helpful by augmenting the effects Kumar, C. (2011). Autohemotherapy in bovine papilloma-
of autogenous vaccine. Auto-hemotherapy for a case report. In: Proceedings of 29th ISVM convention
and National Symposium on Recent Developments in
treatment of chronic diseases in human beings is
Diagnostics and Therapeutics including applications of
an age old practice, but has gained limited public Nanotechnology in Veterinary Medicine, held from
acceptability (Wallis, 1947; Olwin et al., 1997). Feburary 17-19th, Mumbai, India.
413
Bovine cutaneous papillomatosis
Lesnik, F., Bires, J., Suli, J, Posivak, J., Mattova, J., of autogenous vaccine in cutaneous papillomatosis of
Svrcek, S., Sevcikova, Z., Kvokacka, V., Gaspar, V., ongloe heifers. Indian J. Anim. Res. 34: 82-83.
Levkut, M. and Buleca J. (1999). Autovaccination and
Singh, V. and Somvanshi, R. (2010). Spontaneous teat
metabolic profiles at bovine papillomatosis. Slovak Vet.
papillomatosis in Indian cows: A pathological study. Indian
J. 24: 290-94.
J. Vet. Pathol. 34: 5-8.
Lutzner, M.A. (1985). Papilloma virus lesions in
Singh, V., Somvanshi, R. and Tiwari, V.K. (2009).
immunodepression and immunosuppression. Clin.
Papillomatosis in Indian cattle: occurrence and
Dermatol. 3: 165-69.
etiopathology. Indian J. Vet. Pathol. 33: 52-57.
Maeda, Y., Shibahara, T., Wada, Y., Kadota, K., Kanno, Sreeparvathy, M., Harish, C. and Anuraj, K.S. (2011).
T., Uchida, I. and Hatama, S. (2007). An outbreak of Autogenous vaccination as a treatment method for
teat papillomatosis in cattle caused by bovine papilloma bovine papillomatosis. J. Livestock Sci. 2: 38-40.
virus (BPV) type 6 and unclassified BPVs. Vet. Microbiol.
121: 242-48. Turk, N., Zupancic, Z., Staresina, V., Kovac, S., Babic,
T., Kreszinger, M., Curic, S., Barbic, L. and Milas, Z.
Olwin, J.H., Ratajczak, H.V. and House, R.V. (1997). (2005). Severe bovine papillomatosis: detection of bovine
Suc cess ful treatment of hepatic infections by papillomavirus in tumor tissue and efficacy of treatment
autohemotherapy. J. Altern. Complement Med. 3: using autogenous vaccine and parammunity inducer.
155-58. Veterinarski Archiv. 75: 391-97.
Downloaded From IP - 117.220.146.172 on dated 28-Nov-2016
Lesnik, F. and Ledecky, V. (2001). Cellular immunity in cattle. Int. J. Res. Pharma. Biomed Sci. 4: 657-58.
persistent cutaneous papillomatosis of cattle. Folia
www.IndianJournals.com
414